| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 01/14/2009 | EP1187918B2 Tek antagonists |
| 01/14/2009 | CN101346395A Anti-IL-6 antibodies preventing the binding of IL-6 complexed with il-6Ralpha to GP130 |
| 01/14/2009 | CN101343328A Target-specificity dual-mutant amalgamation protein |
| 01/14/2009 | CN101343327A Antiviral protein and uses thereof |
| 01/14/2009 | CN101343326A Cholesterol metabolism regulating and controlling medicament sifting motion system and method with hydroxymethyl glutaryl cozymase A reductase as target point |
| 01/14/2009 | CN100451114C Infuse protein of candida albicans hot shock protein 90 epitope and phage envelop protein , and its uses |
| 01/14/2009 | CN100450551C Recombinated adeno-associated virus genes vaccine for prevention and cure of Alzheimer disease and use thereof |
| 01/13/2009 | US7476722 Chromatography separation using apatite; protein being purified can comprise at least one constant antibody immunoglobulin domain |
| 01/13/2009 | US7476721 Modified cytokines for use in cancer therapy |
| 01/13/2009 | US7476518 Nucleic acids encoding fluorescent proteins and methods of using the same |
| 01/13/2009 | US7476387 Chimeric empty viral-like particles derived from the infectious bursal disease virus (IBDV), process for their production and applications |
| 01/13/2009 | US7476385 Methods of inhibiting IgE responses to thymus-dependent antigens with the anti-gp39 antibody MR1 |
| 01/08/2009 | WO2008143709A3 Multivalent pneumococcal polysaccharide-protein conjugate composition |
| 01/08/2009 | US20090012003 Polypeptides homologous to vegf and bmp1 |
| 01/08/2009 | US20090011499 for modulating or altering T cell function; found on lymphoid derived dendritic cells and display a limited homology to adhesion molecules; generating natural killer cells |
| 01/08/2009 | US20090011497 Peptides and related compounds having thrombopoietic activity |
| 01/08/2009 | US20090011466 Concatameric immunoadhesion molecule |
| 01/08/2009 | US20090010936 Novel Stra6 Polypeptides |
| 01/08/2009 | US20090010933 inhibiting vascularization or angiogenesis using chimeric proteins, immunoglobulin-like domains of tyrosine kinase receptors |
| 01/08/2009 | US20090010917 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor; apoptosis-inducing factor |
| 01/08/2009 | US20090010875 IL-7 Fusion Proteins |
| 01/07/2009 | EP2011877A2 Conjugates for the modulation of immune responses |
| 01/07/2009 | EP2011869A1 Novel anti-cd98 antibody |
| 01/07/2009 | EP2011512A1 An anti HSP90 antibody |
| 01/07/2009 | EP2010572A1 Compositions comprising hpv polypeptides and immunoenhancement peptides for the treatment and prevention of cervical cancer |
| 01/07/2009 | EP2010562A1 Novel polypeptides inducing dendritic cell migration, as well as medicines and pharmaceutical compositions containing same |
| 01/07/2009 | EP1532239B1 Methods and compositions for targeting secretory lysosomes |
| 01/07/2009 | EP1504030B1 Constitutively translocating cell line |
| 01/07/2009 | EP1409684B1 Novel surface exposed immunoglobulin d-binding protein from moraxella catarrhalis |
| 01/07/2009 | EP1220933B1 Purification of recombinant proteins fused to multiple epitopes |
| 01/07/2009 | EP1198581B1 Method for reducing the antigenicity of adeno-associated virus structural protein |
| 01/07/2009 | EP1127065B1 Chlamydia antigen and corresponding dna fragments and uses thereof |
| 01/07/2009 | EP1115874B1 Alzheimer's disease secretase |
| 01/07/2009 | EP1012293B1 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use |
| 01/07/2009 | EP1003879B1 Antigen constructs useful in the detection and differentiation of antibodies to hiv |
| 01/07/2009 | CN101337992A Fusion protein of urokinase type plasminogen activator a chain and melittin and preparation thereof |
| 01/07/2009 | CN101337991A Preparation and applications of rabbit anti-human IRGMa full-length protein polyclone antibody |
| 01/07/2009 | CN100448891C Peptides and related molecules that bind to TALL-1 |
| 01/06/2009 | US7473430 Cancer cell targeting gene delivery method |
| 01/06/2009 | CA2245584C Recombinant expression of s-layer proteins |
| 01/06/2009 | CA2191407C Process for using the yeast adh ii promoter system for the biotechnological production of heterologous proteins in high yields |
| 01/06/2009 | CA2108147C Heterodimeric receptor libraries using phagemids |
| 01/06/2009 | CA1341588C Human ifn-beta2/i1-6, its purification and use |
| 01/01/2009 | US20090005313 Activatable clostridial toxins |
| 01/01/2009 | US20090005312 Novel glp-1 analogues linked to albumin-like agents |
| 01/01/2009 | US20090005298 Bone Sialoprotein Collagen-Binding Peptides |
| 01/01/2009 | US20090004676 T1R3 receptor binding assays for identification of taste modulatory compounds |
| 01/01/2009 | US20090004674 ACPL-related assays |
| 01/01/2009 | US20090004237 B7-Like Molecules and Uses Thereof |
| 01/01/2009 | US20090004226 Fusion proteins of mycobacterium tuberculosis |
| 01/01/2009 | US20090004224 Activatable clostridial toxins |
| 12/31/2008 | WO2009001867A1 Vaccine antigen capable of inducing cross-reacting and neutralizing antibody against high-risk-type human papillomavirus |
| 12/31/2008 | WO2009000089A1 Immunomodulatory compositions and methods for treating disease with modified host defense peptides |
| 12/31/2008 | WO2008116648A3 Novel glp-1 fusion peptides, their production and use |
| 12/31/2008 | WO2007075933A3 Translocation and mutant csf1r kinase in human leukemia |
| 12/31/2008 | EP2009101A1 Antibody modification method for purifying bispecific antibody |
| 12/31/2008 | EP2007815A2 Mono- and bifunctional molecules with ability to bind to g protein-coupled receptors |
| 12/31/2008 | EP2007807A2 Composition and method for mediating an immune response |
| 12/31/2008 | EP1579212B1 Methods of identifying reduced internalization transmembrane receptor agonists |
| 12/31/2008 | EP1512744B1 Pigment protein |
| 12/31/2008 | EP1443960B1 Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases |
| 12/31/2008 | EP1412503B1 A fusion protein |
| 12/31/2008 | EP1294879B1 Thymic stromal lymphopoietin receptor molecules and uses thereof |
| 12/31/2008 | EP1266009B1 ANTI-EGFRvIII SCFVS WITH IMPROVED CYTOTOXICITY AND YIELD, IMMUNOTOXINS BASED THEREON, AND METHODS OF USE THEREOF |
| 12/31/2008 | EP1235073B1 cGMP-VISUALIZING PROBE AND METHOD OF DETECTING AND QUANTIFYING cGMP BY USING THE SAME |
| 12/31/2008 | EP1032672B1 Dna19355 polypeptide, a tumor necrosis factor homolog |
| 12/31/2008 | EP0912730B1 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 12/31/2008 | CN101333259A Preparation of <99m>Tc galactosyl human serum albumin fusion interferon of liver receptor developer and uses thereof |
| 12/31/2008 | CN101333258A Fusion polypeptide with antimicrobial and wound healing promoting function |
| 12/31/2008 | CN100447248C Infusion protein of single chain antibodyA1 and metacide hydrolase, and its preparation method |
| 12/31/2008 | CN100447244C BAFF receptor (BCMA), immunoregulatory agent |
| 12/31/2008 | CN100447156C T2R taste receptors and genes encoding same |
| 12/31/2008 | CA2692171A1 Methods and uses thereof of prosaposin |
| 12/31/2008 | CA2691745A1 Vaccine antigen capable of inducing cross-reacting and neutralizing antibody against high-risk-type human papillomavirus |
| 12/30/2008 | US7470665 Antiproliferatory agents; antitumor agents; mixture of fibroblast growth factor and cytolysis agent |
| 12/30/2008 | US7470432 Antibodies for use in diagnosis, prevention and treatment of autoimmune disease |
| 12/30/2008 | CA2368767C Protease resistant flint analogs |
| 12/30/2008 | CA2117612C Periplasmic membrane-bound system for detecting protein-protein interactions |
| 12/30/2008 | CA2113744C Methods for regulating the immune response using ctla4-binding molecules and il4-binding molecules |
| 12/25/2008 | US20080319173 Blood group antigen fusion polypeptides and methods of use thereof |
| 12/25/2008 | US20080319167 Clostridial toxin derivatives able to modify peripheral sensory afferent functions |
| 12/25/2008 | US20080318839 Ligand activated transcriptional regulator proteins |
| 12/25/2008 | US20080318838 Peptides |
| 12/25/2008 | US20080317773 Conjugates that contain the homeodomain of antennapedia |
| 12/25/2008 | US20080317772 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 12/25/2008 | US20080317750 Antibody antagonists of ve-cadherin without adverse effects on vascular permeability |
| 12/25/2008 | US20080317716 Antigen, nucleic acid that encodes fusion protein; therapy, prevention of tuberculosis infections |
| 12/24/2008 | WO2008156363A1 Selective inhibitors of the nuclear factor of activated t-cells |
| 12/24/2008 | WO2008156249A1 Protein g-oligonucleotide conjugate |
| 12/24/2008 | WO2008155134A1 Biological active proteins having increased in vivo and/or vitro stability |
| 12/24/2008 | WO2008154868A1 Capsid proteins and uses therefore |
| 12/24/2008 | WO2008154867A1 Material with immunogenicity |
| 12/24/2008 | WO2008154814A1 OPTIMIZED TACI-Fc FUSION PROTEINS |
| 12/24/2008 | WO2008154719A1 Recombinant human interferon-like proteins |
| 12/24/2008 | WO2008076487A3 Antibodies and methods for making and using them |
| 12/24/2008 | EP2004844A2 Coadministration of alpha-fetoprotein and a disease modifying anti-rheumatic drug for treating inflammatory arthritic disease |
| 12/24/2008 | EP2004694A2 Methods for preventing and treating amyloidogenic diseases |
| 12/24/2008 | EP1178785B1 Compositions and methods for identifying antigens which elicit an immune response |
| 12/24/2008 | CN101328221A Hypoglycemic polypeptide fused protein, structure and use of derivate thereof |
| 12/24/2008 | CN101328220A Preparation and use of galactosylated human serum albumin fused interferon |